Activate Syrup

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Activate Syrup

Quick Facts Overview

Property Description
Active Ingredient Cyproheptadine
Form Oral Solution (Syrup)
Pharmacological Class First-Generation Antihistamine
Common Use Appetite stimulant / Anorexia treatment
Route of Administration Oral

Activate Syrup is a brand name for a specific liquid medication intended primarily as an appetite stimulant, commonly used to manage significant loss of appetite (anorexia). This oral solution is frequently used in pediatric care or for individuals recovering from illness where promoting increased food intake and weight gain is a clinical goal.

The active ingredient is cyproheptadine hydrochloride, which belongs to the class of first-generation antihistamines. While its original pharmacological purpose is the treatment of allergic conditions, the compound is clinically recognized for a distinct, well-documented side effect of promoting appetite.

This differentiating feature is leveraged by the syrup's formulation. As an oral solution, the medicine allows for flexible and precise dosing, which is particularly suitable for pediatric patients who may struggle with swallowing tablets. The efficacy of cyproheptadine for this off-label use is noted for its role in promoting weight gain in certain populations. Therefore, Activate Syrup is a specialized product that utilizes an officially regulated compound to address nutritional needs through its metabolic effect.

What side effects are possible with Activate Syrup?

Official Side Effects and Safety Profile

The safety profile of Activate Syrup, which contains cyproheptadine, is officially documented by regulatory authorities and classified by the type and frequency of adverse reactions across various organ systems. This section describes only the possible side effects and regulatory safety constraints.


Regulatory Classification of Adverse Reactions

Classification Scope Details from Official Labeling
Most Common Effects Drowsiness and somnolence are classified as Common (occurring in 1% to 10% of patients). These effects are often noted as transient, potentially lessening after the initial few days of administration.
System-Organ Classes Effects span the Nervous System (e.g., dizziness, disturbed coordination), Gastrointestinal (e.g., dry mouth, nausea, constipation), Cardiovascular (e.g., hypotension, tachycardia), and Metabolic and Nutrition (e.g., increased appetite, weight gain).
Serious Adverse Reactions Regulatory documents list potential serious adverse reactions, which are rare, including convulsions, hepatic failure, and certain blood disorders (e.g., agranulocytosis).

Population-Specific Safety Constraints

The medicine is officially contraindicated (prohibited) for use in newborn or premature infants and in nursing mothers. Safety and efficacy are generally not established for children under two years of age. Specific cautions are also required for the older adult population due to an increased regulatory risk for side effects such as dizziness, sedation, and hypotension.

High-level safety constraints note that the drug is contraindicated in certain pre-existing conditions, including narrow-angle glaucoma and an acute asthmatic attack, as explicitly defined in regulatory documents.

Overdose and Emergency Response

Overdose of Activate Syrup (Cyproheptadine) is characterized by a wide spectrum of documented CNS toxicity. Manifestations may range from severe Central Nervous System (CNS) depression (stupor or coma) to paradoxical CNS stimulation (agitation, hallucinations, and convulsions). Anticholinergic signs such as fixed, dilated pupils, dry mouth, and skin flushing are also officially documented.

Official regulatory warnings emphasize the potential for life-threatening systemic events, including respiratory arrest, cardiac arrest, and death. These severe outcomes are specifically noted to be more prevalent in infants and young children, who are more likely to exhibit excitation and convulsions.

Immediate medical attention is required upon suspected overdose. Regulatory documents mandate that emergency services must be contacted immediately if the individual shows signs of a seizure, has trouble breathing, or is unresponsive. Management described in official labels is primarily symptomatic and supportive treatment, involving the monitoring of vital signs and potential use of interventions such as gastric lavage and the administration of activated charcoal. No specific universal antidote is known for general management.

This profile defines the overdose risk and required emergency response as stipulated by regulatory authorities.

Therapeutic Uses of Activate Syrup

What Activate Syrup Treats: Main Uses and Benefits

The therapeutic focus of Activate Syrup is strictly on supporting nutritional health by addressing underlying appetite deficits and the resulting low body mass. The active ingredient is recognized as a medication that can cause increased appetite and weight gain, making it relevant in managing inadequate nutrition.

The medication is commonly used to help with the symptom of significant appetite suppression (anorexia), low body weight, underweight status, and poor growth patterns. This supportive benefit is considered relevant across specific clinical contexts, primarily supporting children with failure to thrive (FTT) and individuals recovering from illnesses that caused severe nutritional compromise.

The primary use of the syrup is to help with the symptom of low appetite. The supportive benefit is applied in addressing this pronounced lack of desire to eat, which supports general well-being during symptomatic phases and assists with maintaining functional stability. By facilitating a sustained increase in food consumption, Activate Syrup supports the process of weight gain and contributes to improved nutritional status. In pediatric care, this supports patients during episodes of heightened discomfort related to feeding.


Quick Fact: Relief for Low Appetite The syrup plays a role in managing specific symptoms related to insufficient calorie intake, providing a supportive function in therapeutic domains related to nutritional restoration and weight management in vulnerable patient groups.

Regulatory References

  1. MedlinePlus Medical Encyclopedia overview on increased appetite

Eligibility and Restrictions for Use

Population Eligibility Rules for Activate Syrup

The eligibility profile for Activate Syrup (Cyproheptadine) is strictly defined by official regulatory documentation, outlining populations for whom use is permitted, restricted, or contraindicated.

Eligible Populations and Age Restrictions

Use is generally permitted for adults, adolescents, and children aged two years and older. However, the safety and effectiveness of the medicine have not been established in pediatric patients below the age of two years.

Absolute Contraindications (Must Not Use)

The medicine is absolutely contraindicated for several populations, including newborn or premature infants, breastfeeding mothers, and elderly, debilitated patients. Use is also prohibited in patients concurrently receiving Monoamine Oxidase Inhibitor (MAOI) therapy.

Condition-Based Exclusions

Activate Syrup is contraindicated in individuals with specific pre-existing conditions, such as angle-closure glaucoma, obstructive gastrointestinal issues like stenosing peptic ulcer, and urinary retention conditions like bladder neck obstruction.

Conditional Use

For pregnant individuals, use is restricted to situations only if clearly needed. Caution is also officially warranted for patients with underlying conditions, including renal impairment, hepatic impairment, or a history of bronchial asthma.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of the active ingredient in Activate Syrup into two primary categories: Pharmacokinetic (PK) interactions and Pharmacodynamic (PD) interactions. PK interactions involve medicines that alter the systemic concentration of the active ingredient, most frequently through modulating specific Cytochrome P450 (CYP) enzymes, leading to clinically significant increases or decreases in drug exposure. For instance, co-administration with strong inhibitors of CYP3A4 is documented to require dosage adjustments due to a predicted increase in plasma levels.

PD interactions concern combinations that create an additive risk for a specific adverse outcome without necessarily altering drug concentration. This includes concomitant use with other medicines known to share the same documented adverse effect, requiring special monitoring. Furthermore, specific non-medicinal products, such as grapefruit juice or certain herbal supplements like St. John's wort, are explicitly restricted or noted in the regulatory label due to their documented capacity to inhibit or induce the drug's metabolism, respectively. Patients should adhere strictly to the constraints outlined in the official Prescribing Information regarding these combinations.

Mechanism of Action

Activate Syrup delivers the compound Calcium Glubionate, which is absorbed in the intestinal lumen. The molecule enters the circulation and influences serum calcium concentration.


The primary action involves two distinct pathways: First, the compound binds to the Calcium-Sensing Receptor (CaSR), a G-protein-coupled receptor located on the surface of parathyroid cells. Activation of the CaSR results in the suppression of parathyroid hormone (PTH) release into the circulation.

Second, the increased systemic availability of calcium is necessary for excitation-contraction coupling in muscle tissue and for neurotransmitter release across synapses. Furthermore, the circulating calcium provides the necessary substrate for bone mineralization. This dual pathway of hormonal feedback and direct metabolic contribution influences calcium homeostasis.

Dosage and Administration Information

How to Use Activate Syrup

Activate Syrup, which contains the active ingredient cyproheptadine, is an oral solution defined by a strict set of administration rules. This section outlines the standardized instructions for proper use, dosing, and administration.

Official Administration and Dosage

Administration Aspect Official Instruction
Route of Administration The syrup is for oral administration (by mouth) only.
Dosing Schedule (Adults) Initial dose is typically 4 mg three times a day (TID). Dosing is highly individualized based on the patient's response and size.
Maximum Adult Dose The total daily dose should generally not exceed 32 mg per day (or 0.5 mg/kg per day).

Practical Instructions and Special Populations

To ensure accuracy, the liquid must be measured using a calibrated measuring device (such as a medical spoon or cup) and not a standard household spoon. The syrup may be taken with or without food.

Population Group Administration Rule
Pediatric Patients Specific daily maximums apply (e.g., 12 mg for children 2–6 years old). The syrup must not be used in newborn or premature infants.
Older Adults The initial dose should typically start at the lower end of the dosing range due to potential changes in organ function.
Renal Impairment Dosing may need to be lowered due to reduced drug clearance.

This structured protocol defines the standardized approach to the administration of the medicine, ensuring compliance with established guidelines.

Recent Clinical Evidence

Research evidence / Overview of Studies for Activate Syrup

Evidence for Use in Managing Appetite Suppression and Low Body Mass

Research examined the use of cyproheptadine as an appetite stimulant, primarily through systematic reviews and Randomized Controlled Trials (RCTs) in underweight individuals and vulnerable patient groups. Studies monitored outcomes including total weight change, Body Mass Index (BMI), and caloric intake. Findings describe patterns observed in the studies where measurements of weight and BMI were reported as increasing in the observed populations over the trial duration. However, evidence is limited when assessing individuals with advanced disease states.


Evidence for Use in Pediatric Nutritional Support

The compound was evaluated in pediatric patients experiencing poor growth, including children with documented Failure to Thrive (FTT). Research examined outcomes related to systemic imbalance, such as Weight/Age Z-scores and linear growth metrics. Studies contribute to the broader evidence landscape, indicating that observed measurements of growth markers showed patterns related to change in these cohorts. A key uncertainty is that many studies used small patient cohorts, and findings were mixed across some results.


Limitations and Research Gaps

Most research focuses on short-term symptom changes, spanning typically 8 to 12 weeks. Long-term effects are not fully established, and the durability of the measured increases is not well characterized beyond the trial periods. The overall evidence quality varies across studies due to heterogeneity and modest sample sizes. Research often relies heavily on outcomes related to physical discomfort (like weight) rather than sufficient data using objective measures for appetite change itself. This research highlights what is known — and what is still uncertain — about the compound’s evaluation over time.

Key Studies & References

  1. Evaluation of Cyproheptadine Hydrochloride Effects on Weight Gain in Underweight Children with Anorexia; A Randomized Clinical Trial

Frequently Asked Questions (FAQ)

Common questions about Activate Syrup (FAQ)


Q: Is Activate Syrup generally considered a medication for long-term or short-term use?

Studies and official information indicate that the available research evidence primarily focuses on short-term symptom changes, spanning typically 8 to 12 weeks. The long-term effects of the active ingredient are described as not fully established beyond the time frames examined in those trials.


Q: Can Activate Syrup cause drowsiness or affect my ability to drive?

Official regulatory labels state that the active ingredient is a first-generation antihistamine which may diminish mental alertness and can cause dizziness or sedation. The regulatory label describes a warning regarding engaging in activities that require mental alertness and motor coordination, such as operating machinery or driving a car.


Q: What should I do if I forget to take a dose of Activate Syrup?

Official patient information describes administration protocols for a missed dose, typically advising that if a dose is missed, it should be taken when remembered, unless it is close to the next scheduled dose. Regulatory documents state patients should not take extra medicine to compensate.


Q: What should I look out for if I think I'm having a serious reaction to Activate Syrup?

The drug is associated with potential serious adverse reactions, though they are rare, including events like convulsions, hepatic failure, and blood disorders. Official regulatory warnings instruct that immediate medical attention should be sought for signs of a severe reaction, such as a seizure, severe confusion, uncontrolled movements, or signs of liver distress (such as yellowed skin or dark urine).


Q: Does the efficacy of Activate Syrup change if taken with or without food?

Administration protocols documented by official sources state that the syrup may be taken with or without food. Regulatory documents do not contain a specific statement defining a change in the drug’s effectiveness based on food intake; the instruction focuses on the administration condition.


Q: What does the official patient information leaflet say about overdose symptoms for Activate Syrup?

Official overdose information indicates that reactions may vary from depression of the central nervous system to stimulation, with excitation sometimes observed, particularly in children. Anticholinergic signs may also occur, such as dry mouth, fixed or dilated pupils, and flushing.


Q: Is there a generic version of Activate Syrup available?

The active ingredient in Activate Syrup, cyproheptadine hydrochloride, is publicly available under its generic name in both syrup and tablet formulations, according to information from regulatory bodies.


Q: Why is Activate Syrup often packaged as a liquid instead of a pill?

The syrup is an oral solution that is packaged to allow for flexible and precise dosing. This formulation is described as being particularly suitable for patient populations, such as pediatric patients, who may struggle with swallowing tablets or require highly individualized dosages.


Q: Can I take Activate Syrup if I have a history of liver issues?

Caution is officially warranted for patients with underlying hepatic impairment (liver issues). Since the drug is metabolized by the liver, official documents indicate that dosing may need to be lowered due to potential changes in drug clearance.


Q: Can Activate Syrup affect the results of common lab tests, like blood work?

Official safety warnings indicate that the active ingredient may be associated with a false positive result in some drug screening tests. Official labeling suggests that stopping the medication may be required before certain allergy skin tests.


Q: How does Activate Syrup compare to similar medications in terms of its mechanism of action?

The active ingredient is pharmacologically classified as a First-Generation Antihistamine and a serotonin and histamine antagonist. While its original purpose was allergy treatment, its use as an appetite stimulant leverages a distinct, well-documented metabolic effect.


Q: What is the process for reporting a side effect related to Activate Syrup to the proper authorities?

Official regulatory information describes a process for reporting adverse events associated with the medicine, noting that patients may report side effects to their healthcare provider or contact the national regulatory agency (such as the FDA in the United States) directly.

--...

Q: Are there any reported interactions between Activate Syrup and blood pressure medicine?

Official documents caution that use is warranted for patients with underlying Cardiovascular disease and Hypertension (high blood pressure). This is due to the potential for certain cardiovascular adverse effects, such as hypotension (low blood pressure) or tachycardia (rapid heart rate), related to the active ingredient's properties.


Q: Is there any information available on how Activate Syrup is eliminated from the body?

Regulatory pharmacokinetic information states that the active ingredient is primarily excreted in the urine. The principal form eliminated from the body is a glucuronide conjugate of cyproheptadine, which is a common metabolic product.


Q: Why do some people report feeling hyperactive or restless after taking Activate Syrup?

While drowsiness is a common effect, the official adverse reaction list also includes central nervous system effects such as restlessness, excitation, and nervousness. Antihistamines may occasionally produce this type of excitation, which is sometimes observed in younger children.


Q: Is Activate Syrup a controlled substance?

The drug is classified by regulatory bodies as having No DEA Schedule. This indicates that the active ingredient in Activate Syrup is not a federally controlled substance.

How should Activate Syrup be stored and disposed of?

How to Store and Dispose of Activate Syrup

Activate Syrup must be stored according to officially documented requirements to maintain its stability and quality. The product must be kept at controlled room temperature, specifically between 20 C to 25 C (68 F to 77 F), with permitted short-term temperature variations up to 30 C (86 F). Storage must occur in the original container. Exposing the syrup to temperatures outside this range or freezing it is prohibited.

Child Safety and Disposal

As a mandatory storage rule, Activate Syrup must be kept out of the reach of children. For disposal, unused or expired medication must be handled according to local regulatory requirements for pharmaceutical waste. Do not dispose of the syrup in household trash or pour it down a drain or toilet unless specifically instructed by local authorities.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Activate Syrup found in:

A-Z Index: